Streetwise Articles
Investors Should Be Paying Attention to Phosphate Right Now
Source: Nick Hodge for Streetwise Reports (9/11/17)
Nick Hodge of The Outsider Club sits down with Arianne Phosphate CEO Brian Ostroff to discuss recent developments at the company.
More >
Jack Chan's Weekly Precious Metals Update
Source: Jack Chan for Streetwise Reports (9/10/17)
Technical analyst Jack Chan charts the latest moves in the gold and silver markets.
More >
The Search for a Large Copper-Gold Discovery in Mexico
Source: Streetwise Reports (9/7/17)
A miner exploring what it believes could be a major gold-copper prophyry just released its initial trenching results.
More >
'Slow-n-Steady Success' Wins Two Buy Recommendations for Gold Explorer
Source: Streetwise Reports (9/7/17)
Resource Maven and Haywood Securities analysts focus on the recent discoveries made and projections for the next drill results.
More >
Update on Oklahoma STACK Play
Source: Clive Maund for Streetwise Reports (9/6/17)
Technical analyst Clive Maund discusses the latest moves by a company that just acquired a large position in Oklahoma's STACK play.
More >
Modern Day Gold Rush: Victoria Gold & Zonte Metals the Eye of the Storm
Source: Ron Struthers for Streetwise Reports (9/6/17)
A new gold rush is on in the Yukon, says Ron Struthers, editor of Struther's Resource Stock Report, who profiles a handful of companies active in the area.
More >
Excelsior Mining Impresses Markets by Receiving APP Permit for Gunnison
Source: The Critical Investor for Streetwise Reports (9/6/17)
With the Aquifer Protection Permit approved, the permitting of the first greenfield copper ISR project is within reach, says The Critical Investor.
More >
Developments at Resource Companies and What the Freeport Deal Means
Source: Adrian Day for Streetwise Reports (9/6/17)
Money manager Adrian Day discusses Freeport's deal in Indonesia and reviews other resource companies in his portfolio.
More >
Silver: The Red-Headed, Freckle-Faced Stepchild
Source: Michael J. Ballanger for Streetwise Reports (9/6/17)
Silver has lagged behind gold, says precious metals expert Michael Ballanger, who explains why he believes that is about to change.
More >
Drilling Expands Silver Company's Resource Area
Source: Streetwise Reports (9/5/17)
Recent drill results announced by this explorer extended the limits of mineralization at one of its Mexican silver mines.
More >
Pure-Play Oklahoma Junior Surrounded by Majors in the STACK
Source: Streetwise Reports (9/5/17)
A growth-oriented oil junior that is acquiring acreage in a red-hot area of Oklahoma paid a fraction of what its neighboring majors are paying.
More >
Multiple Analysts Recommending This Silver-Focused Explorer
Source: Streetwise Reports (9/5/17)
A large silver company and its JV partner have plans in place to increase production at their large project in Mexico.
More >
USD Crashing: Justice at Last
Source: Tom Beck for Streetwise Reports (9/5/17)
As the North Korean crisis escalates, Tom Beck, founder of Portfolio Wealth Global, discusses the rise of gold and other metals.
More >
Bullish Signals for Gold
Source: Clive Maund for Streetwise Reports (9/5/17)
Price and volume action in gold in recent weeks has been very bullish, says technical analyst Clive Maund, as he charts the metal's movements.
More >
Copper's Movements Augur Well for Silver
Source: Clive Maund for Streetwise Reports (9/5/17)
The charts are increasingly looking positive for silver, technical analyst Clive Maund says, and copper's price movements are good news for silver.
More >
Why Korean Tensions Should Soon Ease: The Effect on the Dollar and Precious Metals
Source: Clive Maund for Streetwise Reports (9/5/17)
The tensions centered on the Korean peninsula should soon ease, leading to a rally in the dollar and a (mild) reaction in precious metals and other commodities like copper, says technical analyst Clive Maund.
More >
Velocity Minerals: Exciting Gold Play in Bulgaria
Source: Peter Epstein for Streetwise Reports (9/4/17)
Peter Epstein of Epstein Research discusses Velocity Minerals' recent gold exploration in Bulgaria.
More >
Jack Chan's Weekly Precious Metals Update
Source: Jack Chan for Streetwise Reports (9/2/17)
Technical analyst Jack Chan charts the latest moves in the gold and silver markets.
More >
Q4 Correction?: Warnings from Citigroup, HSBC and Morgan Stanley
Source: Danny Deadlock for Streetwise Reports (9/1/17)
Danny Deadlock, founder of Microcap.com, cites evidence that the last quarter of 2017 could be troubled for financial markets.
More >
Small-Cap Biotech Benefits from First FDA Approval of CAR-T Therapy
Source: Streetwise Reports (9/1/17)
The first approval of a cell therapy for treatment of pediatric blood cancer prompted H. C. Wainwright to increase its price target for a UK-based biotech manufacturing one of the therapy's components.
More >
Zinc: The Bulls Are Circling and Major Miners Are Hungry
Source: Ron Struthers for Streetwise Reports (8/31/17)
Ron Struthers, editor of Struther's Resource Stock Report, profiles a zinc company that he is bullish on.
More >
Good News for Chile, Bad News for the US
Source: Clive Maund for Streetwise Reports (8/31/17)
Technical analyst Clive Maund analyzes why the rising copper price is good news for Chile.
More >
Three Oil & Gas Names for Volatile Times in the Energy Sector
Source: Streetwise Reports (8/31/17)
With oil and gas prices not easy to predict, Samuel Pelaez, chief investment officer and portfolio manager of Galileo Funds, explains the algorithms that track "quantamentals," and discusses several companies that he expects to outperform.
More >
Gold Explorer with Past-Producing, Fully Permitted Arizona Mine Surges
Source: Streetwise Reports (8/30/17)
A past-producing mine in Arizona comes back to life with a new, well-financed and disciplined management team.
More >
With Acquisition of Kite Pharma, Gilead Becomes a 'Major Player' in CAR-T Arena
Source: Streetwise Reports (8/30/17)
Jason Kolbert, analyst with Maxim Group, assesses the billion-dollar transaction that would bring Kite Pharma and the earning potential of its cell therapy programs under the larger biotech's umbrella.
More >